Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 29 September 1978:
Vol. 201. no. 4362, pp. 1232 - 1233
DOI: 10.1126/science.694511

Articles

Science, Vol 201, Issue 4362, 1232-1233
Copyright © 1978 by American Association for the Advancement of Science


articles

Decrease of human serum fucosyltransferase as an indicator of successful tumor therapy

CH Bauer, WG Reutter, KP Erhart, E Kottgen, and W Gerok

Surgical removal of colon carcinomas leads to a decrease in the rate of incorporation of [14C]fucose into its endogenous acceptor in human serum; normal incorporation rates are attained within 14 days. A similar time course has been determined for alpha2- and alpha3-fucosyltransferase when either desialo- or desialodegalactofetuin are employed as exogenous acceptors. A correlation has also been seen between transferase activity and the therapeutic response of patients with breast cancer. These results indicate that the determination of fucosyltransferase activity can facilitate the diagnosis of neoplasia, and the success of surgery, chemotherapy, or radiation.





To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)